IRadimed Corp. IRMD 深 滬
已收盤 02-06 16:00:00 美东时间
95.97
+1.430
+1.51%
華盛通- 最 高96.736
- 今 開95.85
- 成交量 7.77万股
- 最 低 94.85
- 昨 收 94.54
- 總市值 12.21亿
- 52周最高 104.93
- 市盈率 靜 63.78
- 換手率 0.61%
- 52周最低 46.4675
- 委 比 95.97%
- 總股本 1272.12万
- 歷史最高 104.93
- 量 比 0.99
- 振 幅 1.99%
- 歷史最低 1.95
- 每 手 1
- 風險率 16.93%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多iRadimed declares $0.50 special dividend
iRadimed (IRMD) declares $0.50/share special dividend. Payable Dec. 30; for shareholders of record Dec. 17; ex-div Dec. 17. See IRMD Dividend Scorecard, Yield Chart, & Dividend Growth. More on iRadime...
2025-12-08 22:12
iRadimed Declares $0.50/Share Special Cash Dividend Payable December 30, 2025
iRadimed Corporation (the "Company") (NASDAQ:IRMD), announced that its Board of Directors (the "Board") approved a special cash dividend of $0.50 per share of the Company's outstanding common stock. This special cash
2025-12-08 21:43
IRADIMED Announces Special Cash Dividend of $0.50 Per Share
iRadimed Corporation announced a special cash dividend of $0.50 per share, payable on December 30, 2025, to stockholders of record on December 17, 2025. The company, a leader in MRI-compatible medical devices, reported strong financial performance, with $56.5 million in cash and equivalents, enabling the dividend. The Board emphasized maximizing returns for shareholders while considering future needs, including new product commercialization. Futu...
2025-12-08 13:30
IRADIMED CORPORATION declares $0.17 dividend
IRADIMED CORPORATION (irmd) declares $0.17/share quarterly dividend, in line with previous. Payable Nov. 25; for shareholders of record Nov. 14; ex-div Nov. 14. See irmd Dividend Scorecard, Yield Char...
2025-11-04 14:24
iRadimed Sees Q4 GAAP EPS $0.43-$0.47 vs $0.41 Est
iRadimed (NASDAQ:IRMD) is looking for Q4 GAAP EPS of $0.43-$0.47 vs $0.41 analyst estimate..
2025-11-03 21:36
iRadimed Raises FY2025 Adj EPS Guidance from $1.76-$1.86 to $1.84-$1.88 vs $1.82 Est; Raises FY2025 Sales Guidance from $80.000M-$82.500M to $82.500M-$83.500M vs $81.091M Est
iRadimed (NASDAQ:IRMD) raises FY2025 Adj EPS guidance from $1.76-$1.86 to $1.84-$1.88 vs $1.82 analyst estimate. Raises FY2025 sales outlook from $80.000 million-$82.500 million to $82.500 million-$83.500 million vs
2025-11-03 21:35
iRadimed Q3 Adj. EPS $0.47 Beats $0.46 Estimate, Sales $21.202M Beat $20.498M Estimate
iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.46 by 3.3 percent. This is a 9.3 percent increase over earnings of $0.43 per share from the same
2025-11-03 21:33
Earnings Scheduled For November 3, 2025
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
2025-11-03 19:11
IRADIMED CORPORATION to Hold Third Quarter of 2025 Financial Results Conference Call on November 3, 2025
ORLANDO, Fla., Oct. 27, 2025 – Iradimed Corporation announced it will release its 2025 third quarter financial results on November 3, 2025, followed by a conference call at 11:00 a.m. ET. Interested individuals can register for the call via the provided link and access the live webcast on the company’s website. A recording will be available post-call. Iradimed is a leader in MRI-compatible medical devices, offering innovative IV infusion and pati...
2025-10-27 20:05
